Boris Futerman

639 total citations
17 papers, 498 citations indexed

About

Boris Futerman is a scholar working on Molecular Biology, Public Health, Environmental and Occupational Health and Oncology. According to data from OpenAlex, Boris Futerman has authored 17 papers receiving a total of 498 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 6 papers in Public Health, Environmental and Occupational Health and 5 papers in Oncology. Recurrent topics in Boris Futerman's work include Acute Lymphoblastic Leukemia research (5 papers), DNA Repair Mechanisms (4 papers) and Ubiquitin and proteasome pathways (4 papers). Boris Futerman is often cited by papers focused on Acute Lymphoblastic Leukemia research (5 papers), DNA Repair Mechanisms (4 papers) and Ubiquitin and proteasome pathways (4 papers). Boris Futerman collaborates with scholars based in Israel and United States. Boris Futerman's co-authors include Shai Linn, Ofer Ben‐Izhak, Dan Hershko, Maanit Shapira, Medy Tsalic, Micha Barchana, Avraham Ishay, Z. Shen‐Orr, Rafael Luboshitzky and Sergey Postovsky and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Cancer and Fertility and Sterility.

In The Last Decade

Boris Futerman

17 papers receiving 487 citations

Peers

Boris Futerman

ONCOL

PRM

PFM

Tim Crook United Kingdom

Yasuhiro Koikawa Japan

Edwin Alvarez United States

Katsuya Suzuki Japan

Motoaki Chin Japan

Salma Amin United Kingdom

Jane E. Brissenden Canada

Klaus K. Andersen Denmark

Miia Suuriniemi United States

Mona El-Hashimy United States

Tim Crook United Kingdom

Boris Futerman

229 ×0.9

276 ×1.1

ONCOL

83 ×0.9

PRM

36 ×0.6

PFM

41 ×0.9

Citations per year, relative to Boris Futerman Boris Futerman (= 1×) peers Tim Crook

Countries citing papers authored by Boris Futerman

Since Specialization

Citations

This map shows the geographic impact of Boris Futerman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Boris Futerman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Boris Futerman more than expected).

Fields of papers citing papers by Boris Futerman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Boris Futerman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Boris Futerman. The network helps show where Boris Futerman may publish in the future.

Co-authorship network of co-authors of Boris Futerman

This figure shows the co-authorship network connecting the top 25 collaborators of Boris Futerman. A scholar is included among the top collaborators of Boris Futerman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Boris Futerman. Boris Futerman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Khoury, Johad, Michael Weintraub, Elisha Waldman, et al.. (2014). Alkaline phosphatase level change in patients with osteosarcoma: its role as a predictive factor of tumor necrosis and clinical outcome.. PubMed. 16(1). 26–32. 10 indexed citations

Barchana, Micha, et al.. (2013). Cancer Incidence and Survival Among Infants in Israel, 1998–2007. Pediatric Hematology and Oncology. 30(7). 646–654. 6 indexed citations

Peer, Avivit, et al.. (2013). Diabetes Microvascular Disease and the Risk for bisphosphonate-related Osteonecrosis of the Jaw: A Single Center Study. The Journal of Clinical Endocrinology & Metabolism. 98(11). E1807–E1812. 21 indexed citations

Barchana, Micha, et al.. (2013). Cancer incidence and survival among adolescents in Israel during the years 1998 to 2009. Pediatric Blood & Cancer. 60(11). 1848–1854. 3 indexed citations

Elhasid, Ronit, et al.. (2012). Factors Influencing Outcome and Incidence of Late Complications in Children who Underwent Allogeneic Hematopoietic Stem Cell Transplantation for Hemoglobinopathy. Pediatric Hematology and Oncology. 29(8). 694–703. 18 indexed citations

Barchana, Micha, et al.. (2012). Cancer Incidence and Survival Among Children and Adolescents in Israel During the Years 1998 to 2007. Journal of Pediatric Hematology/Oncology. 34(6). 421–429. 22 indexed citations

Beyar‐Katz, Ofrat, Rina Dvir, Joseph Kapelushnik, et al.. (2011). Treatment of T cell lymphoblastic lymphoma in children and adolescents: Israel Society of Pediatric Hematology Oncology retrospective study.. PubMed. 13(3). 161–5. 5 indexed citations

Futerman, Boris, Dina Attias, Rina Dvir, et al.. (2009). Burkitt Lymphoma in Children. Journal of Pediatric Hematology/Oncology. 31(6). 428–436. 9 indexed citations

Ben‐Izhak, Ofer, et al.. (2008). Over-expression of Skp2 is associated with resistance to preoperative doxorubicin-based chemotherapy in primary breast cancer. Breast Cancer Research. 10(4). R63–R63. 43 indexed citations

10.

Postovsky, Sergey, et al.. (2008). Does Regular Follow-up Influence the Survival of Patients With Sarcoma After Recurrence? The Miri Shitrit Pediatric Oncology Department Experience. Journal of Pediatric Hematology/Oncology. 30(3). 189–195. 19 indexed citations

11.

Paz, Shlomit, et al.. (2008). Non-Hodgkin Lymphoma (NHL) linkage with residence near heavy roads—A case study from Haifa Bay, Israel. Health & Place. 15(2). 636–641. 17 indexed citations

12.

Shapira, Maanit, et al.. (2005). The prognostic impact of the ubiquitin ligase subunits Skp2 and Cks1 in colorectal carcinoma. Cancer. 103(7). 1336–1346. 121 indexed citations

13.

Shapira, Maanit, Ofer Ben‐Izhak, Shai Linn, et al.. (2005). The expression of the ubiquitin ligase subunit Cks1 in human breast cancer. Breast Cancer Research. 7(5). R737–44. 81 indexed citations

14.

Shapira, Maanit, Ofer Ben‐Izhak, Bishara Bishara, et al.. (2004). Alterations in the expression of the cell cycle regulatory protein cyclin kinase subunit 1 in colorectal carcinoma. Cancer. 100(8). 1615–1621. 49 indexed citations

15.

Postovsky, Sergey, Shifra Ash, Rina Zaizov, et al.. (2003). Central Nervous System Involvement in Children with Sarcoma. Oncology. 65(2). 118–124. 29 indexed citations

16.

Luboshitzky, Rafael, et al.. (2001). Increased 6-sulfatoxymelatonin excretion in women with polycystic ovary syndrome. Fertility and Sterility. 76(3). 506–510. 43 indexed citations

17.

Sprecher, Eli, Adel Shalata, Boris Futerman, et al.. (2000). Androgenetic alopecia in heterozygous carriers of a mutation in the human hairless gene. Journal of the American Academy of Dermatology. 42(6). 978–982. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact